Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Change in Intangibles (2024 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Change in Intangibles for 2 consecutive years, with $3.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Intangibles changed N/A to $3.0 million in Q3 2025 year-over-year; TTM through Dec 2025 was $3.0 million, a 40.0% decrease, with the full-year FY2025 number at $3.0 million, down 40.0% from a year prior.
  • Change in Intangibles was $3.0 million for Q3 2025 at Madrigal Pharmaceuticals, down from $5.0 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $5.0 million in Q2 2024 to a low of $3.0 million in Q3 2025.